InvestorsHub Logo
Followers 467
Posts 26910
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 130

Tuesday, 06/12/2012 10:10:43 AM

Tuesday, June 12, 2012 10:10:43 AM

Post# of 176
7:22AM On The Wires (WIRES) Alkermes (ALKS) announced that Janssen Research & Development has initiated a phase 3 clinical research program for a three-month formulation of INVEGA SUSTENNA, an injectable medicine for the treatment of schizophrenia.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALKS News